We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$133B
AUM Growth
+$2.97B
(+2.3%)
Cap. Flow
+$494M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
28.35%
Holding
293
New
7
Increased
75
Reduced
134
Closed
7
Avg Time Held
3.4
years
Top 10 Avg Time Held
3.7
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$635M |
| 2 |
United Airlines
UAL
|
+$620M |
| 3 |
Qualcomm
QCOM
|
+$401M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$302M |
| 5 |
Whirlpool
WHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$442M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$411M |
| 3 |
Adobe
ADBE
|
+$359M |
| 4 |
Texas Instruments
TXN
|
+$345M |
| 5 |
AT&T
T
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.7% |
| 2 | Healthcare | 23.28% |
| 3 | Industrials | 16.25% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Financials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Adobe
ADBE
$97.9B
| $4.69B | 3.52% |
21,702,128
-1,766,603
| -8% | -$359M |
2013 Q2
19 quarters
|
|
2
Eli Lilly
LLY
$1.12T
| $4.22B | 3.17% |
54,546,783
-605,794
| -1% | -$48.8M |
2013 Q2
19 quarters
|
|
3
Biogen
BIIB
$34.8B
| $4.09B | 3.07% |
14,953,231
-156,000
| -1% | -$48.4M |
2013 Q2
19 quarters
|
|
4
Southwest Airlines
LUV
$20B
| $4B | 3% |
69,883,831
-598,320
| -0.8% | -$35.9M |
2013 Q2
19 quarters
|
|
5
Microsoft
MSFT
$4.01T
| $3.83B | 2.87% |
41,934,453
-2,900,475
| -6% | -$265M |
2013 Q2
19 quarters
|
|
|
6
Texas Instruments
TXN
$255B
| $3.81B | 2.86% |
36,635,092
-3,188,726
| -8% | -$345M |
2013 Q2
19 quarters
|
|
7
Amgen
AMGN
$235B
| $3.66B | 2.74% |
21,442,344
-587,905
| -3% | -$108M |
2013 Q2
19 quarters
|
|
8
FedEx
FDX
$69.9B
| $3.65B | 2.74% |
15,212,552
-263,815
| -2% | -$66.7M |
2013 Q2
19 quarters
|
|
9
Micron Technology
MU
$1.05T
| $3.03B | 2.27% |
58,128,345
-262,266
| -0.4% | -$12.6M |
2013 Q2
19 quarters
|
|
10
Alibaba
BABA
$276B
| $2.8B | 2.1% |
15,241,243
-138,685
| -0.9% | -$26.1M |
2014 Q3
14 quarters
|
|
|
11
NVIDIA
NVDA
$5.25T
| $2.8B | 2.1% |
482,959,000
-75,242,200
| -13% | -$442M |
2013 Q2
19 quarters
|
|
12
American Airlines Group
AAL
$8.13B
| $2.75B | 2.06% |
52,924,171
+2,063,357
| +4% | +$111M |
2013 Q4
17 quarters
|
|
13
JPMorgan Chase
JPM
$891B
| $2.56B | 1.92% |
23,261,550
-97,385
| -0.4% | -$11M |
2015 Q1
12 quarters
|
|
|
14
United Airlines
UAL
$32.9B
| $2.52B | 1.89% |
36,260,399
+8,976,847
| +33% | +$620M |
2013 Q2
19 quarters
|
|
15
NetApp
NTAP
$42.2B
| $2.44B | 1.83% |
39,608,999
-376,621
| -0.9% | -$23M |
2013 Q2
19 quarters
|
|
16
Alphabet (Google) Class A
GOOGL
$4.27T
| $2.36B | 1.77% |
45,457,740
-1,087,080
| -2% | -$60.3M |
2015 Q3
10 quarters
|
|
17
Alphabet (Google) Class C
GOOG
$4.22T
| $2.32B | 1.74% |
44,952,140
-1,176,560
| -3% | -$64.9M |
2013 Q2
19 quarters
|
|
18
Nektar Therapeutics
NKTR
$1.29B
| $2.24B | 1.68% |
1,404,126
-86,375
| -6% | -$111M |
2013 Q2
19 quarters
|
|
19
Sony
SONY
$144B
| $2.1B | 1.58% |
217,506,860
-722,140
| -0.3% | -$7.11M |
2013 Q2
19 quarters
|
|
20
AstraZeneca
AZN
$259B
| $1.8B | 1.35% |
25,782,719
+2,776,402
| +12% | +$192M |
2015 Q3
10 quarters
|
|
21
Novartis
NVS
$286B
| $1.76B | 1.32% |
24,349,415
-80,521
| -0.3% | -$6.13M |
2013 Q2
19 quarters
|
|
22
Hewlett Packard
HPE
$77.8B
| $1.69B | 1.27% |
96,530,145
-907,179
| -0.9% | -$15.4M |
2015 Q4
9 quarters
|
|
23
Charles Schwab
SCHW
$163B
| $1.68B | 1.26% |
32,213,155
-2,555,115
| -7% | -$137M |
2013 Q2
19 quarters
|
|
24
Delta Air Lines
DAL
$51.4B
| $1.54B | 1.16% |
28,113,495
+32,771
| +0.1% | +$1.81M |
2013 Q2
19 quarters
|
|
25
Caterpillar
CAT
$338B
| $1.4B | 1.05% |
9,485,675
-92,654
| -1% | -$14.6M |
2013 Q2
19 quarters
|
|
Similar funds
Primecap Management's Q1 2018 Portfolio in Review
As of Q1 2018, Primecap Management held 293 positions worth $133B, up 2.3% from $130B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.8%. Primecap Management opened 7 new positions and exited 7, leaving the 293-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2018 buy was Moody's: 181,000 shares worth $29.2M.
- Primecap Management added most to Bristol-Myers Squibb in Q1 2018, an estimated $635M increase.
- Primecap Management's biggest Q1 2018 reduction was NVIDIA, cutting an estimated $442M.
- Primecap Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $411M.
- Primecap Management's ten largest holdings make up 28% of its $133B portfolio in Q1 2018.
- Primecap Management opened 7 new positions and closed 7 in Q1 2018.
- Primecap Management's portfolio value rose 2.3% quarter-over-quarter to $133B.
Based on Primecap Management's 13F filing for Q1 2018, filed 14 May 2018.